tenofovir disoproxil maleate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablet bottle AUST R: 265834Active ingredients:
emtricitabine
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
20 May 2024
to
30 Apr 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.
|
TENOFOVIR DISOPROXIL VIATRIS tenofovir disoproxil maleate 300 mg film coated tablet bottle AUST R: 261093Active ingredients:
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
10 Dec 2024
to
30 Apr 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
Alternative generic products are available.
|
TENOFOVIR DISOPROXIL/EMTRICITABINE/EFAVIRENZ Viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle AUST R: 280721Active ingredients:
efavirenz
emtricitabine
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
11 Apr 2025
to
30 Apr 2025
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
The sponsor is closely controlling the supply.
|